As of 2024-07-27, the Intrinsic Value of Charles River Laboratories International Inc (CRL) is
270.98 USD. This CRL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 233.47 USD, the upside of Charles River Laboratories International Inc is
%.
The range of the Intrinsic Value is 200.79 - 407.66 USD
270.98 USD
Intrinsic Value
CRL Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
200.79 - 407.66 |
270.98 |
16.1% |
| DCF (Growth 10y) |
283.83 - 540.39 |
371.56 |
59.1% |
| DCF (EBITDA 5y) |
371.06 - 449.96 |
418.85 |
79.4% |
| DCF (EBITDA 10y) |
442.84 - 571.93 |
513.24 |
119.8% |
| Fair Value |
145.11 - 145.11 |
145.11 |
-37.84% |
| P/E |
258.47 - 315.12 |
287.19 |
23.0% |
| EV/EBITDA |
269.83 - 345.34 |
305.44 |
30.8% |
| EPV |
81.68 - 113.64 |
97.66 |
-58.2% |
| DDM - Stable |
60.12 - 140.54 |
100.33 |
-57.0% |
| DDM - Multi |
141.95 - 261.62 |
184.42 |
-21.0% |
CRL Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
12,026.04 |
| Beta |
1.50 |
| Outstanding shares (mil) |
51.51 |
| Enterprise Value (mil) |
14,362.09 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.69% |
| Cost of Debt |
4.32% |
| WACC |
9.33% |